107 results on '"Kresak, Adam"'
Search Results
2. Genetic Defect in Submucosal Gland–Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk
3. Discovery and Initial Characterization of Long Intergenic Noncoding RNAs Associated With Esophageal Adenocarcinoma
4. Proteins Involved in Focal Cell Adhesion and Podosome Formation Are Differentially Expressed during Colorectal Tumorigenesis in AOM-Treated Rats
5. Superovulation with gonadotropin-releasing hormone agonist or chorionic gonadotropin for ovulation trigger differentially affects leukocyte populations in the peri-implantation mouse uterus
6. Iron Supplementation Increases Tumor Burden and Alters Protein Expression in a Mouse Model of Human Intestinal Cancer.
7. Genetic Defect in Submucosal Gland–Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk
8. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer
9. IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1‐like B‐acute lymphoblastic leukaemia.
10. Supplementary Figures from Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer
11. Supplementary Data from Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer
12. Data from Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer
13. Mucin 4 (MUC4) Protein is Expressed in B-Acute Lymphoblastic Leukemia (B-ALL) and is restricted to BCR::ABL1 Positive and BCR::ABL-like Subtypes
14. Data from MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
15. Supplementary Video from MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
16. Legends for Video and Figures 1-3 from MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
17. Supplementary Methods from MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
18. Supplementary Figures 1-3 from MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
19. Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer
20. The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett’s Neoplasia
21. HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus
22. RET Mutation and Expression in Small-Cell Lung Cancer
23. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI
24. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs
25. The EphB2-MYC Axis is a Major Determinant of Barrett’s Pathobiology and a Therapeutic Vulnerability in Esophageal Cancer
26. 930 MUTATIONS IN XANTHENE DEHYDROGENASE (XDH) ASSOCIATED WITH INHERITED SUSCEPTIBILITY TO BARRETT'S NEOPLASIA
27. Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
28. Defining the role of RUNX1T1 in "combined" small cell lung cancer.
29. Su1062 – Molecular Dependencies in Esophageal Adenocarcinoma: A Systems Biology Approach
30. Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer.
31. A nonrandomized trial of vitamin D supplementation for Barrett’s esophagus
32. Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
33. RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
34. Association Between Germline Mutation inVSIG10Land Familial Barrett Neoplasia
35. Correction: Prion Protein Protects against Renal Ischemia/Reperfusion Injury
36. Prion Protein Protects against Renal Ischemia/Reperfusion Injury
37. Abstract 2815: Sulindac reversal of 15-PGDH mediated resistance to colon tumor chemoprevention with NSAIDs
38. Su1963 Large-Scale Transcriptome Sequencing Identifies Two Signaling Sub-Networks As Critical Mediators of Barrett's Carcinogenesis
39. CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma
40. PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
41. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs
42. Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival
43. Use of CD30 expression in human malignant mesothelioma as a novel therapeutic target.
44. Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.
45. Elevated Ribonucleotide Reductase Levels Associate With Suppressed Radiochemotherapy Response in Human Cervical Cancers
46. MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
47. Tumor number and comparative micro‐array analysis of tumor and adjacent non‐tumor intestinal tissue after iron supplementation in ApcMin/+ mice
48. The Technological History of Immunohistochemical Methods and Applications in Clinical Cancer Diagnosis and Research.
49. MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents.
50. Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.